Product Information
66082-1-PBS targets CISD2-Specific in WB, IHC, IF/ICC, Indirect ELISA applications and shows reactivity with human, zebrafish, rat, mouse samples.
| Tested Reactivity | human, zebrafish, rat, mouse |
| Host / Isotype | Mouse / IgG2b |
| Class | Monoclonal |
| Type | Antibody |
| Immunogen |
Recombinant protein Predict reactive species |
| Full Name | CDGSH iron sulfur domain 2 |
| Observed Molecular Weight | 15 kDa |
| GenBank Accession Number | NM_001008388 |
| Gene Symbol | CISD2 |
| Gene ID (NCBI) | 493856 |
| RRID | AB_11232425 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Protein A purification |
| UNIPROT ID | Q8N5K1 |
| Storage Buffer | PBS only, pH 7.3. |
| Storage Conditions | Store at -80°C. |
Background Information
CISD2 gene encodes a 15 kDa CDGSH iron-sulfur domain-containing protein 2, which is also named Miner1 or NAF-1, this protein was reported on endoplasmic reticulum membrane or mitochondrion outer membrane. Defects in CISD2 are the cause of Wolfram syndrome type 2 (WFS2), a rare disorder characterized by juvenile-onset insulin-dependent diabetes mellitus with optic atrophy. CISD2 regulates autophagy program by interacting BCL2, contributing to antagonize BECN1-mediated cellular autophagy at the endoplasmic reticulum. This monoclonal antibody is specific to CISD2 and does not cross-react with CISD1.
Publications
What published studies show
The CISD2-Specific Monoclonal Antibody (3D7A3), catalog number 66082-1-PBS, has a total of 7 citations. One indexed citation appears in Frontiers in Pharmacology (2024), investigating how CISD2 inhibition enhances doxorubicin sensitivity in diffuse large B-cell lymphoma through regulation of ferroptosis and ferritinophagy. Associated research fields include cancer biology, ferroptosis, autophagy, and pharmacology.
| Species | Application | Title |
|---|---|---|
Front Pharmacol Inhibition of CISD2 enhances sensitivity to doxorubicin in diffuse large B-cell lymphoma by regulating ferroptosis and ferritinophagy |





















